Computed tomography imaging-guided radiotherapy by targeting upconversion nanocubes with significant imaging and radiosensitization enhancements

Scientific Reports

Volumn 3, Issue , 2013, Pages

  Xing, Huaiyong ^a   Zheng, Xiangpeng ^b   Ren, Qingguo ^b   Bu, Wenbo ^a   Ge, Weiqiang ^b   Xiao, Qingfeng ^a   Zhang, Shengjian ^c   Wei, Chenyang ^a   Qu, Haiyun ^a   Wang, Zheng ^a   Hua, Yanqing ^b   Zhou, Liangping ^c   Peng, Weijun ^c   Zhao, Kuaile ^c   Shi, Jianlin ^a  

^a SHANGHAI INSTITUTE OF CERAMICS   (China)

^b FUDAN UNIVERSITY   (China)

^c FUDAN UNIVERSITY SHANGHAI CANCER CENTER   (China)

Author keywords

[No Author keywords available]

Indexed keywords

CONTRAST MEDIUM; HEAVY METAL; NANOMATERIAL; RADIOSENSITIZING AGENT;

CHEMISTRY; COMPUTER ASSISTED TOMOGRAPHY; DIAGNOSTIC IMAGING; HUMAN; NEOPLASMS; PROCEDURES; TUMOR CELL LINE; ARTICLE; METHODOLOGY; NEOPLASM; RADIOTHERAPY;

CELL LINE, TUMOR; CONTRAST MEDIA; DIAGNOSTIC IMAGING; HUMANS; METALS, HEAVY; NANOSTRUCTURES; NEOPLASMS; RADIATION-SENSITIZING AGENTS; RADIOTHERAPY; TOMOGRAPHY, X-RAY COMPUTED;

EID: 84877782968     PISSN: None     EISSN: 20452322     Source Type: Journal    
DOI: 10.1038/srep01751     Document Type: Article

References (60)

1. McMahon, S., Mendenhall, M., Jain, S. & Currell, F. Radiotherapy in the presence of contrast agents: a general figure of merit and its application to gold nanoparticles. Phys.Med. Biol. 53, 5635-5651 (2008).
2. Kobayashi, K., Usami, N., Porcel, E., Lacombe, S. & Le Sech, C. Enhancement of radiation effect by heavy elements. Mutat. Res-Rev. Mutat. 704, 123-131 (2010).
3. Le Duc, G. et al. Toward an image-guided microbeam radiation therapy using gadolinium-based nanoparticles. Acs Nano 5, 9566-9574 (2011).
4. Hainfeld, J. F., Dilmanian, F. A., Slatkin, D. N. & Smilowitz, H. M. Radiotherapy enhancement with gold nanoparticles. J. Pharm. Pharmacol. 60, 977-985 (2008).
5. Hainfeld, J. F. et al. Gold nanoparticles enhance the radiation therapy of a murine squamous cell carcinoma. Phys. Med. Biol. 55, 3045-3059 (2010).
6. Suit, H. D. & Gerweck, L. E. Potential for hyperthermia and radiation therapy. Cancer Res. 39, 2290-2298 (1979). (Pubitemid 9185425)
7. Edholm, P. Computed tomography-new technique in diagnostic radiology. P. Roy. Soc. B-Biol. Sci. 195, 277-279 (1977). (Pubitemid 8012088)
8. Munzenrider, J. E., Pilepich, M., Reneferrero, J. B., Tchakarova, I. & Carter, B. L. Use of body scanner in radiotherapy treatment planning. Cancer 40, 170-179 (1977). (Pubitemid 8160519)
9. Bourin, M., Jolliet, P. & Ballereau, F. An overview of the clinical pharmacokinetics of X ray contrast media. Clin. Pharmacokinet. 32, 180-193 (1997). (Pubitemid 27122519)
10. Shilo, M., Reuveni, T., Motiei, M. & Popovtzer, R. Nanoparticles as computed tomography contrast agents: current status and future perspectives. Nanomedicine-Uk 7, 257-269 (2012).
11. Liu, Y., Ai, K. & Lu, L. Nanoparticulate X-ray computed tomography contrast agents: from design validation to in vivo applications. Accounts Chem. Res. 45, 1817-1827 (2012).
12. Maeda, H. The enhanced permeability and retention (EPR) effect in tumor vasculature: the key role of tumor-selective macromolecular drug targeting. Adv. Enzyme Regul. 41, 189-207 (2001).
13. Greish, K. Enhanced permeability and retention of macromolecular drugs in solid tumors: a royal gate for targeted anticancer nanomedicines. J. Drug Target. 15, 457-464 (2007). (Pubitemid 47209047)
14. Hainfeld, J. F., Slatkin, D. N., Focella, T. M. & Smilowitz, H. M. Gold nanoparticles: a new X-ray contrast agent. Brit. J. Radiol. 79, 248-253 (2006).
15. Rabin, O., Manuel Perez, J., Grimm, J., Wojtkiewicz, G. & Weissleder, R. An X-ray computed tomography imaging agent basedonlong-circulating bismuth sulphide nanoparticles. Nat. Mater. 5, 118-122 (2006). (Pubitemid 43177900)
16. Oh, M. H. et al. Large-scale synthesis of bioinert tantalum oxide nanoparticles for X-ray computed tomography imaging and bimodal image-guided sentinel lymph node mapping. J. Am. Chem. Soc. 133, 5508-5515 (2011).
17. 4 upconversion nanocrystals via an OA/ionic liquid two-phase system for in vivo dual modality imaging. Adv. Funct. Mater. 21, 4470-4477 (2011).
18. 4:Yb, Er/Tm nanostructure for MRI, CT and upconversion luminescence tri-modality imaging. Biomaterials 33, 4618-4627 (2012).
19. Hainfeld, J. F. et al. Micro-CT enables microlocalisation and quantification of Her2-targeted gold nanoparticles within tumour regions. Brit. J. Radiol. 84, 526-533 (2011).
20. Kinsella, J. M. et al. X-Ray computed tomography imaging of breast cancer by using targeted peptide-labeled bismuth sulfide nanoparticles. Angew. Chem. Int. Ed. 50, 12308-12311 (2011).
21. Xing, H. et al. Multifunctional nanoprobes for upconversion fluorescence, MR and CT trimodal imaging. Biomaterials 33, 1079-1089 (2012).
22. Liu, Y. et al. A high-performance ytterbium-based nanoparticulate contrast agent for in vivo X-ray computed tomography imaging. Angew. Chem. Int. Ed. 51, 1437-1442 (2012).
23. 31 nanoprobe for CT and NIR-to-NIR fluorescent bimodal imaging. Biomaterials 33, 5384-5393 (2012).
24. 3 up-conversion nanoparticle as an in vivo X-Ray CT imaging contrast agent. Biomaterials 33, 6748-6757 (2012).
25. Seiwert, T. Y., Salama, J. K. & Vokes, E. E. The chemoradiation paradigm in head and neck cancer. Nat. Clin. Prac. Oncol. 4, 156-171 (2007). (Pubitemid 46358853)
26. Boige, V. & Ducreux, M. Prevention and treatment of chemotherapy-induced digestive toxicities. B. Cancer 88, 163-173 (2001). (Pubitemid 32238728)
27. Forastiere, A. A. et al. Concurrent chemotherapy and radiotherapy for organ preservation in advanced laryngeal cancer. New Engl. J. Med. 349, 2091-2098 (2003). (Pubitemid 37464533)
28. Koo, H. et al. In vivo targeted delivery of nanoparticles for theranosis. Accounts Chem. Res. 44, 1018-1028 (2011).
29. McMahon, S. J. et al. Biological consequences of nanoscale energy deposition near irradiated heavy atom nanoparticles. Sci. Rep. 1, 1-9 (2011).
30. Das, I. J. & Kahn, F. M. Backscatter dose perturbation at high atomic number interfaces in megavoltage photon beams. Med. Phys. 16, 367-375 (1989). (Pubitemid 19160845)
31. Douglass, M., Bezak, E. & Penfold, S. Developmentof a randomized 3D cell model for Monte Carlo microdosimetry simulations. Med. Phys. 39, 3509-3519 (2012).
32. Hainfeld, J. F., Slatkin, D. N. & Smilowitz, H. M. The use of gold nanoparticles to enhance radiotherapy in mice. Phys. Med. Biol. 49, 309-315 (2004).
33. Berbeco, R. I. et al. DNA damage enhancement from gold nanoparticles for clinical MV photonbeams. Radiat. Res. 178, 604-608 (2012).
34. Rahman, W. N. et al. Enhancement of radiation effects by gold nanoparticles for superficialradiation therapy. Nanomed-Nanotechnol. 5, 136-142 (2009).
35. Berbeco, R. I., Ngwa, W. & Makrigiorgos, G. M. Localized dose enhancement to tumor blood vessel endothelial cells via megavoltage X-rays and targeted gold nanoparticles: new potential for external beam radiotherapy. Int. J. Radiat. Oncol. 81, 270-276 (2011).
36. Liu, C. J. et al. Enhancement of cell radiation sensitivity by pegylated gold nanoparticles. Phys. Med. Biol. 55, 931-945 (2010).
37. McMahon, S. J. et al. Nanodosimetric effects of gold nanoparticles in megavoltage radiation therapy. Radiother. Oncol. 100, 412-416 (2011).
38. Chithrani, D. B. et al. Gold nanoparticles as radiation sensitizers in cancer therapy. Radiat. Res. 173, 719-728 (2010).
39. Jain, S. et al. Cell-specific radiosensitization by gold nanoparticles at megavoltage radiation energies. Int. J. Radiat. Oncol. 79, 531-539 (2011).
40. Wang, F. et al. Simultaneous phase and size control of upconversion nanocrystals through lanthanide doping. Nature 463, 1061-1065 (2010).
41. Nam, S. H. et al. Long-term real-time tracking of lanthanide ion doped upconverting nanoparticles in living cells. Angew. Chem. Int. Ed. 50, 6093-6097 (2011).
42. Zhou, J., Liu, Z. & Li, F. Upconversion nanophosphors for small-animal imaging. Chem. Soc. Rev. 41, 1323-1349 (2012).
43. Cai, W. & Chen, X. Multimodality molecular imaging of tumor angiogenesis. J. Nucl. Med. 49, 113S-128S (2008). (Pubitemid 351948040)
44. 5 nanoparticles: novel binary contrast agent for high resolution invivo X-ray computed tomography angiography. Adv. Health. Mat. 1, 461-466 (2012).
45. Wang, D. et al. Aggregation-enhanced fluorescence in PEGylated phospholipid nanomicelles for in vivo imaging. Biomaterials 32, 5880-5888 (2011).
46. http://physics.nist.gov/PhysRefData/XrayMassCoef [Accessed 20 July 2012]
47. Xiong, L. et al. High contrast upconversion luminescence targeted imaging in vivo using peptide-labeled nanophosphors. Anal. Chem. 81, 8687-8694 (2009).
48. Kim, Y. H. et al. Tumor targeting and imaging using cyclic RGD-PEGylated gold nanoparticle probes with directly conjugated iodine-125. Small 7, 2052-2060 (2011).
49. 3-integrin-expressing glioma cells and only accumulates in the vascular tumor compartment. Radiology 253, 462-469 (2009).
50. Dubey, P. K., Singodia, D., Verma, R. K. & Vyas, S. P. RGD modified albumin nanospheres for tumour vasculature targeting. J. Pharm. Pharmacol. 63, 33-40 (2011).
51. Xiong, L., Yang, T., Yang, Y., Xu, C. & Li, F. Long-term in vivo biodistribution imaging and toxicity of polyacrylic acid-coated upconversion nanophosphors. Biomaterials 31, 7078-7085 (2010).
52. Cheng, L., Yang, K., Shao, M. W., Lu, X. H. & Liu, Z. In vivo pharmacokinetics, long-term biodistribution and toxicology study of functionalized upconversion nanoparticles in mice. Nanomedicine-Uk 6, 1327-1340 (2011).
53. Chen, Y. et al. Multifunctional mesoporous composite nanocapsules for highly efficient MRI-guided high-intensity focused ultrasound cancer surgery. Angew. Chem. Int. Ed. 50, 12505-12509 (2011).
54. Terreno, E., Uggeri, F. & Aime, S. Image guided therapy: the advent of theranostic agents. J. Control. Release 161, 328-337 (2012).
55. Koo, H. et al. In vivo targeted delivery of nanoparticles for theranosis. Accounts Chem. Res. 44, 1018-1028 (2011).
56. Hak, S. et al. The effect of nanoparticle polyethylene glycol surface density on ligand directed tumor targeting studied in vivo by dual modality imaging. Acs Nano 6, 5648-5658 (2012).
57. Wang, X., Zhuang, J., Peng, Q. & Li, Y. A general strategy for nanocrystal synthesis. Nature 437, 121-124 (2005). (Pubitemid 41613436)
58. Chen, F. et al. A "neck-formation" strategy for an antiquenching magnetic/upconversion fluorescent bimodal cancer probe. Chem. Eur. J. 16, 11254-11260 (2010).
59. Li, L. et al. Biomimetic surface engineering of lanthanide-doped upconversion nanoparticles as versatile bioprobes. Angew. Chem. Int. Ed. 51, 6121-6125 (2012).
60. Peter, M. F., Derek, C. K., Mark, D. D. & John, C. G. Polymer gels for magnetic resonance imaging of radiation dose distributions at normal room atmosphere. Phys. Med. Biol. 46, 3105-3113 (2001).